Coronavirus patients treated with drug for children’s disease recovered sooner than a placebo
A drug for a children’s immune disease helped coronavirus patients recover faster, a new study suggests. Ruxolitinib is approved to treat Hemophagocytic Lymphohistiocytosis (HLH), which is a severe systemic inflammatory syndrome among youngsters that can be fatal, by calming down the immune system’s overreaction. Scientists from Cincinnati Children’s Hospital in Ohip say that 10 times … Read more